Evidence map›Paper›PMID 35411453›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2022

Study of protease activity from Aspergillus awamori INCQS2B.361U2/1 extracellular fraction and modification of culture medium composition to isolate a novel aspartic protease.

Raquel Elisa da Silva-López, Thayane Aparecida Alves de Araujo, Hélvio José Jalles Monteiro, Érika Maria Gomes Ferreira Teixeira, Lucas Tupi, Elba Pinto da Silva Bon

Open access · greenAbstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Raquel Elisa da Silva-LópezDepartment of Natural Products, Institute of Pharmaceuticals Technology, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, RJ, Brazil. raquel.lopez@far.fiocruz.br.ORCID http://orcid.org/0000-0003-2744-7884
Thayane Aparecida Alves de AraujoDepartment of Natural Products, Institute of Pharmaceuticals Technology, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
Hélvio José Jalles MonteiroDepartment of Natural Products, Institute of Pharmaceuticals Technology, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
Érika Maria Gomes Ferreira TeixeiraDepartment of Natural Products, Institute of Pharmaceuticals Technology, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
Lucas TupiBioethanol Laboratory, Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Elba Pinto da Silva BonBioethanol Laboratory, Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Fundação Oswaldo Cruz · BRUniversidade Federal do Rio de Janeiro · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 490029/2009-4)FIOCRUZ, PROEP CNPq/ FARMANGUINHOS -407839/2017-8
6 · The paper itself

Abstract

Aspergillus awamori was cultivated in a modified Breccia medium, and the extracellular fraction was obtained, which presented 260 ± 15 µg of protein/mg and specific protease activity of 3.87 ± 0.52 mM.min

Indexed as

Aspartic Acid ProteasesAspergillusHydrogen-Ion ConcentrationPepstatinsPeptide HydrolasesAspartic Acid ProteasesPepstatinsPeptide HydrolasesAspartic protease isolationAspergillus awamoriCulture medium modification supplementationEnzyme characterizationExtracellular fraction

Identifiers

PMID35411453
PMCPMC9433587
OpenAlexW4223477960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.